EL SEGUNDO, Calif. — Gov. Gavin Newsom announced Thursday that CalRx biosimilar insulin glargine pens will be available to consumers in California beginning Jan. 1, 2026. The launch comes amid the ...

A low-fat vegan diet—without cutting calories or carbs—may help people with type 1 diabetes significantly reduce how much insulin they need, and how much they spend on it. In a new analysis published ...

Medtronic plans to launch the MiniMed Go app this spring. The company said the feature helps people using insulin pens with glycemic control. A retrospective analysis found the average time in range, ...

Insulin remains one of the most important treatments for people living with diabetes. Whether someone has Type 1 diabetes or advanced Type 2 diabetes, insulin therapy helps control blood sugar levels, ...

CivicaScript, a nonprofit generic drug company, has launched insulin glargine-yfgn and ustekinumab-aauz, expanding its national portfolio of low-cost treatments. The insulin product, which is ...

Emma Kleck has been totally dependent on insulin, the lifesaving medication for people living with diabetes, for 25 years. Kleck, 32, of Santa Cruz, was diagnosed with the rarer Type 1 diabetes at age ...

EXPECTING SOME FREEZING TEMPERATURES TO START ROLLING IN SCOTT. I FEEL LIKE THIS HAS TO BE THE BUZZ AT EVERY BREAK ROOM AT WORK THIS WEEK. HAVE YOU HEARD ABOUT THE COLD WEATHER THAT’S COMING? LOOK AT ...

CVS has agreed to pay almost $38 million to settle allegations that its pharmacies overcharged the government for insulin pens over a decade, putting to bed a Department of Justice lawsuit and several ...

CVS Health (CVS) has reached a settlement with the U.S. government, requiring the company to pay $37.76M to resolve claims that it overbilled government healthcare programs for insulin pens. The ...

NEW YORK, Dec 2 (Reuters) - CVS Health will pay $37.76 million to settle allegations it dispensed too many insulin pens to patients, and then obtained improper reimbursements from Medicare, ‌Medicaid ...